SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is currently the subject of intense retail debate following unverified social media claims that Michael Burry has opened a significant short position in the stock. While bulls view the price volatility as a manipulation tactic by institutional "shorts" to shake out weak hands before upcoming earnings, others remain cautious of the stock's recent technical weakness and the broader risks surrounding heavy institutional positioning in the AI infrastructure sector.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and massive trading volume following a strong earnings report that featured record revenue growth and raised guidance, fueling intense community speculation about a potential short squeeze. Traders are actively debating whether this momentum will lead to a sustained breakout or follow historical patterns of post-earnings profit-taking as investors weigh the company's aggressive expansion strategy against significant short interest.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing extreme volatility and intense community speculation ahead of its upcoming earnings report, with sentiment deeply divided between investors betting on a long-term value turnaround and those anticipating a potential capitulation drop. The stock is currently being heavily scrutinized for its aggressive short interest and performance laggards, as traders watch closely for any signals of a pivot or institutional accumulation.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is facing intense volatility as the market reacts to a significant earnings miss characterized by a decline in core brand sales and margin pressure. Investors are actively debating whether the pullback represents a long-term accumulation opportunity or a structural shift in growth, with community sentiment deeply divided between those betting on a recovery through product diversification and those concerned by rising competition.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros shares are experiencing significant volatility following a mixed market reaction to strong quarterly earnings, where investors are balancing robust revenue growth and raised guidance against concerns over margin compression and high valuation multiples. Community discussion remains polarized, with bulls pointing to the company's aggressive store expansion and intense customer loyalty as indicators of a long-term compounder, while bears express caution regarding near-term headwinds like rising operational costs and the stock's premium price tag.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are experiencing extreme volatility following a second-quarter report where revenue and guidance fell slightly short of high market expectations, despite strong year-over-year growth and a resolved SEC inquiry. The community is sharply divided, with many traders labeling the aggressive sell-off an emotional overreaction or manipulation, while others argue the stock's premium valuation is finally facing a necessary reality check as growth rates stabilize.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon Enterprise is facing intense volatility as investors weigh fundamental concerns about margin erosion and stock-based compensation against the company's long-term potential in public safety technology. The community remains deeply divided, with some traders focusing on technical breakdowns and insider selling activity, while others highlight the durability of the firm's recurring software revenue and its aggressive AI-driven expansion as a reason to buy the current dip.

Chime Financial, Inc. engages in the design and development of a digital banking application. Its mobile app, Chime, provides online banking, fee-free overdraft, mobile banking, automatic savings, mobile payments, and security and control capabilities. The company was founded by Christopher R. Britt and Ryan King in 2012 and is headquartered in San Francisco, CA.

Chime Financial Inc - Ordinary Shares - Class A

Chime Financial, Inc.

Chime Financial is seeing active community discussion as traders debate whether its recent volatility and post-IPO price correction present a contrarian buying opportunity or a deeper valuation trap ahead of upcoming earnings. Market participants are intensely focused on the company's revenue growth trajectory and path to profitability, with many highlighting the contrast between the firm's expanding user base and its ongoing share price pressure.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is drawing intense community focus as traders debate its potential for a bullish reversal, with many actively monitoring whale accumulation, potential upcoming regulatory clarity, and the activation of hard fork upgrades. Discussions remain sharply divided between long-term believers who are aggressively accumulating the asset and skeptics who are concerned by stagnant user activity and downward price trends.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending after reporting a record-breaking earnings quarter that smashed revenue expectations and demonstrated significant margin improvements, fueling strong community optimism. Investors are actively discussing the company's surging organic demand, upcoming pipeline catalysts, and the potential for a major short squeeze as bullish sentiment builds around the firm's commercial momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

The consensus price target hints at a 38.6% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of +40.00% and +1.98%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now

Si-Bone (SIBN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 71.1% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%

The consensus price target hints at a 65.3% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Why Si-Bone Stock Soared by Almost 20% on Tuesday

Key PointsIt posted rather encouraging first-quarter results...

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of +41.18% and +2.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

SI-Bone (SIBN) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Globus Medical (GMED) Tops Q1 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of +22.07% and +4.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -4.35% and +7.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

$SIBN Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.09 up 35.71% YoY
• Reported revenue of $56.01M up 15.18% YoY
• SI-BONE increases 2026 worldwide revenue guidance to a range of $231 million to $233 million, representing ~15% to 16% growth, while maintaining gross margin at ~79% and updating operating expenses to ~12%.

Stocktwits

SI-BONE Inc

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.09 up 35.71% YoY
• Reported revenue of $56.01M up 15.18% YoY
• SI-BONE increases 2026 worldwide revenue guidance to a range of $231 million to $233 million, representing ~15% to 16% growth, while maintaining gross margin at ~79% and updating operating expenses to ~12%.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$SIBN Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.09 up 35.71% YoY
• Reported revenue of $56.01M up 15.18% YoY
• SI-BONE increases 2026 worldwide revenue guidance to a range of $231 million to $233 million, representing ~15% to 16% growth, while maintaining gross margin at ~79% and updating operating expenses to ~12%.

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SIBNSI-BONE Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SIBN News